Loading clinical trials...

RECRUITINGNCT05204017

Comprehensive Analysis Platform To Understand, Remedy and Eliminate ALS

CAPTURE ALS is a long-term data and biorepository platform that will facilitate future ALS research. CAPTURE ALS will provide the standardized systems and tools necessary to collect, store, and analyz...

Lead sponsor: University of Alberta•4 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Claire Magnussen, PhD

CONTACT

514-398-6188 info@captureals.ca

Sara Moradipoor

CONTACT

780-248-1805 moradipo@ualberta.ca

Related studies

RECRUITINGPhase 3

Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS

NCT07322003 · Amyotrophic Lateral Sclerosis

RECRUITINGPhase 1/2

Evaluation of the Combined Therapy of EH-301 and N-acetylcysteine Together With Riluzole in Amyotrophic Lateral Sclerosis (ALS)

NCT07414212 · Amyotrophic Lateral Sclerosis

RECRUITINGPhase 1

Safety and Tolerability Study of CTx1000 In Participants With Amyotrophic Lateral Sclerosis

NCT07401121 · ALS (Amyotrophic Lateral Sclerosis)

RECRUITING

Intermuscular Coherence as a Biomarker for ALS

NCT05104710 · Amyotrophic Lateral Sclerosis

RECRUITING

Retinal Imaging in Neurodegenerative Disease

NCT03233646 · Alzheimer's Disease, Mild Cognitive Impairment, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 13, 2026Terms

Trial snapshot

StatusRECRUITING

Phase—

Enrollment150

Start dateSep 2021

Last updatedApr 13, 2026

Condition

Amyotrophic Lateral Sclerosis Primary Lateral Sclerosis Progressive Muscular Atrophy Frontotemporal Degeneration

Locations shown

University of Alberta

Edmonton, Alberta

University of Toronto / Sunnybrook Health Sciences Centre

Toronto, Ontario

McGill University / Montreal Neurological Institute and Hospital

Montreal, Quebec

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 13, 2026Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions